nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—Skin candida—Epirubicin—thyroid cancer	0.032	0.032	CcSEcCtD
Cefdinir—Allergic cutaneous angiitis—Sorafenib—thyroid cancer	0.0314	0.0314	CcSEcCtD
Cefdinir—Nephropathy—Vandetanib—thyroid cancer	0.0311	0.0311	CcSEcCtD
Cefdinir—Amylase increased—Vandetanib—thyroid cancer	0.0311	0.0311	CcSEcCtD
Cefdinir—Skin candida—Doxorubicin—thyroid cancer	0.0296	0.0296	CcSEcCtD
Cefdinir—Amylase increased—Sorafenib—thyroid cancer	0.021	0.021	CcSEcCtD
Cefdinir—Ileus—Vandetanib—thyroid cancer	0.0209	0.0209	CcSEcCtD
Cefdinir—Interstitial lung disease—Vandetanib—thyroid cancer	0.0209	0.0209	CcSEcCtD
Cefdinir—Interstitial pneumonia—Sorafenib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Sorafenib—thyroid cancer	0.0204	0.0204	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Epirubicin—thyroid cancer	0.0146	0.0146	CcSEcCtD
Cefdinir—Interstitial lung disease—Sorafenib—thyroid cancer	0.0141	0.0141	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Doxorubicin—thyroid cancer	0.0135	0.0135	CcSEcCtD
Cefdinir—Rhabdomyolysis—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Cefdinir—Cardiac failure—Vandetanib—thyroid cancer	0.011	0.011	CcSEcCtD
Cefdinir—Neutropenia—Vandetanib—thyroid cancer	0.00868	0.00868	CcSEcCtD
Cefdinir—Erythema nodosum—Epirubicin—thyroid cancer	0.00853	0.00853	CcSEcCtD
Cefdinir—Pneumonia—Vandetanib—thyroid cancer	0.00833	0.00833	CcSEcCtD
Cefdinir—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00829	0.00829	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00821	0.00821	CcSEcCtD
Cefdinir—Renal failure—Vandetanib—thyroid cancer	0.00814	0.00814	CcSEcCtD
Cefdinir—Stomatitis—Vandetanib—thyroid cancer	0.00807	0.00807	CcSEcCtD
Cefdinir—Hepatic failure—Sorafenib—thyroid cancer	0.00806	0.00806	CcSEcCtD
Cefdinir—Conjunctivitis—Vandetanib—thyroid cancer	0.00805	0.00805	CcSEcCtD
Cefdinir—Haematuria—Vandetanib—thyroid cancer	0.00789	0.00789	CcSEcCtD
Cefdinir—Erythema nodosum—Doxorubicin—thyroid cancer	0.00789	0.00789	CcSEcCtD
Cefdinir—Leukorrhea—Epirubicin—thyroid cancer	0.00787	0.00787	CcSEcCtD
Cefdinir—Renal failure acute—Sorafenib—thyroid cancer	0.00785	0.00785	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00768	0.00768	CcSEcCtD
Cefdinir—Haemoglobin—Vandetanib—thyroid cancer	0.00747	0.00747	CcSEcCtD
Cefdinir—Haemorrhage—Vandetanib—thyroid cancer	0.00743	0.00743	CcSEcCtD
Cefdinir—Cardiac failure—Sorafenib—thyroid cancer	0.00742	0.00742	CcSEcCtD
Cefdinir—Vaginal moniliasis—Epirubicin—thyroid cancer	0.00731	0.00731	CcSEcCtD
Cefdinir—Leukorrhea—Doxorubicin—thyroid cancer	0.00728	0.00728	CcSEcCtD
Cefdinir—Erythema multiforme—Vandetanib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Epirubicin—thyroid cancer	0.00702	0.00702	CcSEcCtD
Cefdinir—Vaginal moniliasis—Doxorubicin—thyroid cancer	0.00676	0.00676	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Epirubicin—thyroid cancer	0.00675	0.00675	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00653	0.00653	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00653	0.00653	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Doxorubicin—thyroid cancer	0.00649	0.00649	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Doxorubicin—thyroid cancer	0.00624	0.00624	CcSEcCtD
Cefdinir—Vaginal discharge—Epirubicin—thyroid cancer	0.00606	0.00606	CcSEcCtD
Cefdinir—Neutropenia—Sorafenib—thyroid cancer	0.00586	0.00586	CcSEcCtD
Cefdinir—Loss of consciousness—Vandetanib—thyroid cancer	0.00569	0.00569	CcSEcCtD
Cefdinir—Pneumonia—Sorafenib—thyroid cancer	0.00562	0.00562	CcSEcCtD
Cefdinir—Vaginal discharge—Doxorubicin—thyroid cancer	0.00561	0.00561	CcSEcCtD
Cefdinir—Convulsion—Vandetanib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Cefdinir—Hypertension—Vandetanib—thyroid cancer	0.00559	0.00559	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00554	0.00554	CcSEcCtD
Cefdinir—Chest pain—Vandetanib—thyroid cancer	0.00551	0.00551	CcSEcCtD
Cefdinir—Acute coronary syndrome—Sorafenib—thyroid cancer	0.0055	0.0055	CcSEcCtD
Cefdinir—Renal failure—Sorafenib—thyroid cancer	0.00549	0.00549	CcSEcCtD
Cefdinir—Myocardial infarction—Sorafenib—thyroid cancer	0.00547	0.00547	CcSEcCtD
Cefdinir—Jaundice—Sorafenib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Cefdinir—Stomatitis—Sorafenib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Cefdinir—Dry mouth—Vandetanib—thyroid cancer	0.00539	0.00539	CcSEcCtD
Cefdinir—Ileus—Epirubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Cefdinir—Thrombocytopenia—Vandetanib—thyroid cancer	0.00517	0.00517	CcSEcCtD
Cefdinir—Haemoglobin—Sorafenib—thyroid cancer	0.00504	0.00504	CcSEcCtD
Cefdinir—Haemorrhage—Sorafenib—thyroid cancer	0.00501	0.00501	CcSEcCtD
Cefdinir—Ileus—Doxorubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Cefdinir—Insomnia—Vandetanib—thyroid cancer	0.00478	0.00478	CcSEcCtD
Cefdinir—Erythema multiforme—Sorafenib—thyroid cancer	0.00474	0.00474	CcSEcCtD
Cefdinir—Dyspepsia—Vandetanib—thyroid cancer	0.00465	0.00465	CcSEcCtD
Cefdinir—Decreased appetite—Vandetanib—thyroid cancer	0.00459	0.00459	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00456	0.00456	CcSEcCtD
Cefdinir—Constipation—Vandetanib—thyroid cancer	0.00451	0.00451	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00432	0.00432	CcSEcCtD
Cefdinir—Abdominal pain—Vandetanib—thyroid cancer	0.00417	0.00417	CcSEcCtD
Cefdinir—Body temperature increased—Vandetanib—thyroid cancer	0.00417	0.00417	CcSEcCtD
Cefdinir—Dyskinesia—Epirubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Cefdinir—Leukopenia—Sorafenib—thyroid cancer	0.00391	0.00391	CcSEcCtD
Cefdinir—Loss of consciousness—Sorafenib—thyroid cancer	0.00384	0.00384	CcSEcCtD
Cefdinir—Asthenia—Vandetanib—thyroid cancer	0.00379	0.00379	CcSEcCtD
Cefdinir—Hypertension—Sorafenib—thyroid cancer	0.00377	0.00377	CcSEcCtD
Cefdinir—Pruritus—Vandetanib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Cefdinir—Vaginal inflammation—Epirubicin—thyroid cancer	0.00369	0.00369	CcSEcCtD
Cefdinir—Dry mouth—Sorafenib—thyroid cancer	0.00363	0.00363	CcSEcCtD
Cefdinir—Dyskinesia—Doxorubicin—thyroid cancer	0.00363	0.00363	CcSEcCtD
Cefdinir—Diarrhoea—Vandetanib—thyroid cancer	0.00361	0.00361	CcSEcCtD
Cefdinir—Melaena—Epirubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Cefdinir—Anaphylactic shock—Sorafenib—thyroid cancer	0.00356	0.00356	CcSEcCtD
Cefdinir—Candida infection—Epirubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cefdinir—Shock—Sorafenib—thyroid cancer	0.0035	0.0035	CcSEcCtD
Cefdinir—Dizziness—Vandetanib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Cefdinir—Thrombocytopenia—Sorafenib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Cefdinir—Anorexia—Sorafenib—thyroid cancer	0.00339	0.00339	CcSEcCtD
Cefdinir—Vomiting—Vandetanib—thyroid cancer	0.00336	0.00336	CcSEcCtD
Cefdinir—Rash maculo-papular—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Cefdinir—Rash—Vandetanib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Cefdinir—Dermatitis—Vandetanib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Cefdinir—Headache—Vandetanib—thyroid cancer	0.00331	0.00331	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—thyroid cancer	0.00326	0.00326	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Cefdinir—Nausea—Vandetanib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Cefdinir—Dyspepsia—Sorafenib—thyroid cancer	0.00313	0.00313	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Cefdinir—Decreased appetite—Sorafenib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00307	0.00307	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Cefdinir—Constipation—Sorafenib—thyroid cancer	0.00305	0.00305	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Cefdinir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00291	0.00291	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Cefdinir—Body temperature increased—Sorafenib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Cefdinir—Abdominal pain—Sorafenib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Cefdinir—Purpura—Epirubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—thyroid cancer	0.00268	0.00268	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Cefdinir—Hypersensitivity—Sorafenib—thyroid cancer	0.00262	0.00262	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Cefdinir—Asthenia—Sorafenib—thyroid cancer	0.00256	0.00256	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Cefdinir—Pruritus—Sorafenib—thyroid cancer	0.00252	0.00252	CcSEcCtD
Cefdinir—Diarrhoea—Sorafenib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Cefdinir—Dizziness—Sorafenib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Cefdinir—Asthma—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Cefdinir—Vomiting—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Cefdinir—Rash—Sorafenib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cefdinir—Dermatitis—Sorafenib—thyroid cancer	0.00224	0.00224	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Cefdinir—Headache—Sorafenib—thyroid cancer	0.00223	0.00223	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Cefdinir—Nausea—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Cefdinir—Agitation—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Cefdinir—Shock—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Cefdinir—Shock—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Cefdinir—Constipation—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000996	0.000996	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—thyroid cancer	0.00097	0.00097	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—thyroid cancer	0.000963	0.000963	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—thyroid cancer	0.000963	0.000963	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—thyroid cancer	0.000944	0.000944	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—thyroid cancer	0.000931	0.000931	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—thyroid cancer	0.000874	0.000874	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—thyroid cancer	0.000862	0.000862	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—thyroid cancer	0.000837	0.000837	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—thyroid cancer	0.000833	0.000833	CcSEcCtD
Cefdinir—Rash—Epirubicin—thyroid cancer	0.00083	0.00083	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—thyroid cancer	0.000829	0.000829	CcSEcCtD
Cefdinir—Headache—Epirubicin—thyroid cancer	0.000825	0.000825	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Cefdinir—Nausea—Epirubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—thyroid cancer	0.000774	0.000774	CcSEcCtD
Cefdinir—Rash—Doxorubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Cefdinir—Headache—Doxorubicin—thyroid cancer	0.000763	0.000763	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—thyroid cancer	0.000723	0.000723	CcSEcCtD
